Clinical Trial

Efficacy and Safety of rhTPO in Combination With Cyclosporine Versus Cyclosporine Alone in the Treatment of TD-NSAA

Unknown Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated July 29, 2024 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Investigating the efficacy and safety of rhTPO in combination with cyclosporine versus cyclosporine alone for the treatment of TD-NSAA
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06525948
Lead Sponsor Peking Union Medical College Hospital
Conditions Aplastic Anemia, Transfusion-dependent Anemia
Enrollment 54 participants
Start Date 2024-07-30
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-07-29